Tokyo, Dec. 19 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060113) titled 'Observational Study After an Aesthetic treatment' on Dec. 19.
Study Type:
Observational
Primary Sponsor:
Institute - Kao Corporation
Condition:
Condition - Acquired melanin pigmentation/Benign tumors
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Observation after laser (CO2, Q-switched) and IPL treatments on benign small tumors and acquired pigmentation: A longitudinal study of the wound healing process
Basic objectives2 - Others
Eligibility:
Age-lower limit - 20
years-old
=
Gender - Male and Female
Key inclusion criteria - (1) Men and women aged between 20 and 59 years old.
(2) Those who wish to undergo or are planning to undergo aesthetic treatment.
(3) Patients with benign small tumors (seborrheic keratosis, soft fibroma, etc.) or acquired hyperpigmentation (senile hyperpigmentation, spermatorrhea, etc.) as determined by the principal
investigator.
Key exclusion criteria - (1) Those who suffer from chronic inflammatory skin diseases (atopic dermatitis, psoriasis, etc.).
(2) Those who have extreme sunburn on the face.
(3) Those who have a tendency to develop keloids.
(4) Those who are determined by the principal investigator to require treatment for a disease.
(5) Women who are breastfeeding, pregnant, or potentially pregnant.
(6) Those who are otherwise determined to be unsuitable by the Principal Investigator.
Target Size - 30
Recruitment Status:
Recruitment status - Completed
Date of protocol fixation - 2021 Year 08 Month 20 Day
Date of IRB - 2021 Year 08 Month 20 Day
Anticipated trial start date - 2021 Year 08 Month 30 Day
Last follow-up date - 2022 Year 01 Month 24 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068742
Disclaimer: Curated by HT Syndication.
